International Society of Glomerular Disease

EXPLORE OUR MEMBERS-ONLY COMMUNITY SITE

The ISGD team and membership committee are excited to invite all of our members to join our free, members-only community site for an authentic networking space where ISGD members connect with each other and elevate our collective efforts towards building the future of glomerular science and medicine. You can use the site to sign up for ISGD projects (or share information about your own), find opportunities for research collaboration, learn about upcoming events, look up colleagues in the member directory, connect with others by interest or geography, discuss scientific and clinical questions, and more.

EXPLORE THE COMMUNITY

A doctor's hand with a stethoscope and iPad

TOUCH

Who?

The International Society of Glomerular Disease is a medical society founded in 2022 to provide a physician- and researcher-centric professional home for glomerular disease experts.

ISGD was initially envisioned by NephCure and its network of glomerular health leaders. It is now an independent nonprofit 501(c)(6) organization. We continue to collaborate with NephCure and other allied organizations to advance our shared goals.

pexels-cottonbro-studio-7578808_crop_800px

TOUCH

Why?

Following decades of research and dedication, we are witnessing exponential advances in glomerular medicine. From basic and translational research to clinical treatments, this is an exciting inflection point in our field. Yet crucial needs of many patients with glomerular disease remain unmet.

The care of patients with these rare diseases requires unique training and commitment. Glomerular disease specialists around the world lead these efforts in all aspects of research and treatment, and form a vital subspecialty of nephrology.

THE UNMET NEEDS

We are bringing together glomerular experts to unite our subspecialty and address major challenges in clinical care.

GET PATIENTS TO EXPERTS SOONER

The average adult patient does not see a glomerular specialist until 12–18 months after symptom onset...if ever. Every month with proteinuria means irreversible kidney damage. We're going to change that.

NAVIGATE THERAPEUTIC OPTIONS

For too long, our only options have been steroids, immunosuppressants, and off-label chemotherapy. As the menu of available therapies grows, we'll need to share knowledge and best practices so that every patient can benefit.

DEVELOP FUTURE TREATMENTS

There are currently more than 60 clinical trials in progress for glomerular disease—an unimaginable number just a few years ago. Let's keep the momentum going.

OUR FOCUS AREAS

RECOGNITION AND CREDENTIALING
- Standards for “glomerular disease expert” designation
- Connecting other healthcare providers with glomerular experts
PEER SUPPORT
- Practice establishment
- Creation of Centers of Excellence and glomerular disease clinics
- Community building and leadership development
EDUCATION
- Development of best practices for glomerular disease education — both fellowship training and continuing medical education
- Working with allied organizations to promote the creation of local fellowship programs
CLINICAL TRIALS
- Clinical trial training, connections, and support
- Expanding equitable patient access to trials
BASIC AND TRANSLATIONAL RESEARCH
- Discussion and dissemination of research
- Connections and collaborative opportunities
- Research support